Ascendis Pharma A/S reports results for the quarter ended in September - Earnings Summary

Ascendis Pharma A/S

10/11/2021 22:54

* Ascendis Pharma A/S  ASND.OQ  reported a quarterly adjusted
loss of €1.47​​ per share for the quarter ended in September.
The mean expectation of ten analysts for the quarter was for a
loss of €2.29 per share.
* Revenue fell 59.6% to €1.11 million from a year ago;  analysts
expected €1.14 million. 
* Ascendis Pharma A/S's reported EPS for the quarter was a loss
of €1.47​.
* The mean earnings estimate of analysts had fallen by
about 3.8% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Ascendis Pharma A/S shares had fallen by 0.4% this quarter and
lost 4.8% so far this year.
* The company reported a quarterly loss of €80.35 million.
* Wall Street's median 12-month price target for Ascendis Pharma
A/S is $193.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 10:53 p.m.
 ​All figures in euros unless otherwise stated